Idarucizumab administration in emergency situations: the Munich Registry of Reversal of Pradaxa® in clinical routine (MR REPAIR).
Clemens KüpperKatharina FeilMatthias KleinRegina FeuereckerMarc LückingFlorian ThanbichlerDennis DietrichIrene ZerkaulenMitja JandlMartin MarziniakHolger PoppertSilke WunderlichHelge TopkaMarianne DieterichLars KellertPublished in: Journal of neurology (2019)
In our study, we have shown that the administration of Idarucizumab is a rare intervention and restricted to patients with severe bleeding complications or ischemic stroke. The clinical outcome of patients who received Idarucizumab in emergency situations was poor.